Muzaffar H. Qazilbash MD

PubMed

• CD70-Targeting CAR-NK Cells Overcome BCMA Downregulation and Improve Survival in High-Risk Multiple Myeloma Models.
  Paul Lin, Sunil Acharya, Francia Reyes-Silva, Rafet Basar, Nadima Uprety
  Blood Cancer Discovery. 2025-10-27
• Outcomes of Patients With Multiple Myeloma With deletion 1p Following Autologous Stem Cell Transplant.
  Curtis Marcoux, Denái R Milton, Mark R Tanner, Qaiser Bashir, Samer Srour
  Transplantation and Cellular Therapy. 2025-10-01
• A case series of oral decitabine-cedazuridine with venetoclax for blastic plasmacytoid dendritic cell neoplasm.
  Hannah Goulart, Guillermo Garcia-Manero, Tapan M Kadia, Naval Daver, Courtney D DiNardo
  Leukemia & Lymphoma. 2025-09-01

Journal Articles

• Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction Drugs  
  Krina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature
• Pilot Study Using Post-Transplant Cyclophosphamide (PTCy), Tacrolimus and Mycophenolate GVHD Prophylaxis for Older Patients Receiving 10/10 HLA-Matched Unrelated Donor...  
  Uday R Popat, Amin Alousi, Issa F Khouri, Muzaffar Qazilbash, Richard E Champlin, Partow Kebriaei, Simrit Parmar, Chitra Hosing, Nature

Abstracts/Posters

• Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell Transplantation
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Outcomes of Lenalidomide Retreatment with Novel Triplet Regimens in Multiple Myeloma Patients Progressing on Lenalidomide-Based Maintenance Therapy: A Single Center Re...
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Primary Plasma Cell Leukemia Outcomes Remain Dismal Despite Novel Agents and Hematopoietic Cell Transplantation
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receivi...
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Commonly Presents in the Setting of Prior or Concomitant Hematologic Malignancies (PCHM): Patient Characteristics ...
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Allogeneic Hematopoietic Cell Transplantation May Improve Long-Term Outcomes in Patients with Ph-like Acute Lymphoblastic Leukemia with CRLF2 Overexpression
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Novel Prognostic Scoring System for Autologous Hematopoietic Cell Transplantation (AHCT) in Multiple Myeloma (MM)
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Breaking the Glass Ceiling of Age in Transplant in Multiple Myeloma
  Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Outcome of Autologous Stem Cell Transplantation in Waldenström's Macroglobulinemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018